Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESBrian E. Miller, Ph.D. Is Appointed TMRW SVP of Sales - 25+...

Brian E. Miller, Ph.D. Is Appointed TMRW SVP of Sales – 25+ Plus Veteran of the Fertility Industry Executive

March 5, 2021

Brian E. Miller, Ph.D. will be responsible for bringing TMRW‘s innovative technology to fertility clinics in the United States.

In addition, Brian will also be integral to the ongoing development of new products and services that will expand TMRW’s offerings, enabling fertility clinics to further enhance and automate their clinical lab operations.

A veteran of the fertility industry, Brian has over 25 years of experience at the nexus of science and technology, scaling fertility products and solutions and bringing them to market to improve patient care. Brian has an extensive background in biotech and pharma sales, medical affairs, medical practice operations, business development, government affairs, clinical laboratory and research, and alliance partner management. Brian has a profound understanding of the clinicians and patients who he works with, which has allowed him to foster deep and long-lasting relationships with his clients.

Brian joins TMRW from CooperSurgical, the fertility, genomics, and women’s health division of The Cooper Companies (NYSE: COO), where he led all fertility and genomic solutions and patient advocacy for North America.

Previously, Brian was Chief Commercial Officer at Recombine, a clinical genetic testing company specializing in carrier screening which was acquired by CooperSurgical in 2016. He also served as Chief Operating Officer at the Fertility Centers of New England.  Earlier in his career, Brian held multiple senior positions at EMD Serono, where he helped lead a medical affairs team and managed all U.S. strategic accounts for endocrinology and fertility sales.  At Organon, as a medical liaison, he supported the science and launch of new products through education.

Brian began his career as an andrologist at the Hospital of Central Connecticut, and advanced to Associate Director of Clinical Research and reproductive endocrinology and andrology lab supervisor. He completed a Ph.D. from the University of Connecticut.

Alan Murray, TMRW’s Founder and Co-CEO commented: “Brian is one of the best known and most respected executives in the fertility field. Over his two decade career, he has won the trust and admiration of the leading clinicians and innovators in not only the fertility space, but also the many key intersecting disciplines such as genetic testing and lab operations. We could not be more delighted by his arrival to further TMRW’s appeal to innovators in the fertility space.”

“TMRW is leading the way in developing how IVF will be practiced in the future,” said Brian. “The automation revolution TMRW is leading is already benefiting clinicians and patients alike. I’m excited to join a team of innovators, who, in a short period of time, took an extraordinary vision to bring safety to cryospecimen management and developed a game-changing technology solution that will become the community standard in IVF labs worldwide. I am thrilled to be part of the ongoing innovation which is TMRW’s future.”

Brian’s appointment comes on the heels of TMRW’s commercial launch in February 2021.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy